Olema Pharmaceuticals, Inc. (OLMA) Misses Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts OLMA Hot Sheet
Join SI Premium – FREE
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q2 EPS of ($0.51), $0.13 worse than the analyst estimate of ($0.38).
For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADP Employment Change (Aug) 38K vs 47K Expected
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- GlobalFoundries and RAAAM to develop next-gen on-chip memory for AI
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
